VXRT News and Press, Vaxart Inc. From 09/02/20

One of my investments is in a small COVID vaccine company, Heat Biologics ( HTBX ), and I generally route for the little guy. So I don't particularly like writing an article that has a number of facts and reasons why probably none of the remaining small players are going to become major player...

Introduction Vaxart ( VXRT ) is a small cap, clinical-stage biotech company, based in South San Francisco, Calif., that develops oral vaccines, which the company believes represent "an important advancement in vaccination technology". I have previously written a SA article on VXRT , if ...

COVID-19 vaccine stocks have easily been the hottest niche across the entire market since March. Developmental-stage companies like Inovio Pharmaceuticals (NASDAQ: INO) , Moderna (NASDAQ: MRNA) , Novavax (NASDAQ: NVAX) , Vaxart (NASDAQ: VXRT) , and Heat Biologics (NASDAQ: HTBX) a...

Vaxart (NASDAQ: VXRT) is one of the most dynamic coronavirus vaccine stocks of the year so far, with its share price growing from less than a dollar in January to nearly $17 in mid-July. While Vaxart has since fallen to around $7 as its speculation-induced bubble continues to deflate, the co...

Are These The Top 3 Coronavirus Stocks To Buy Or Sell Right Now? Shares of companies involved in the coronavirus fight have been leading stock market gains over the past few months. Investors see these biotechnology or pharmaceutical companies in headlines so often that some analysts call ...

"Sanofi (NASDAQ: SNY ) expects to move to a large late-stage trial with an experimental coronavirus vaccine toward the end of the year," said CEO Paul Hudson at a conference in France. More news on: Sanofi, GlaxoSmithKline plc, Pfizer Inc., Healthcare stocks news, Read more ...

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced the appointment of Karen J. Wilson to its Board of Directors ...

Few stocks have delivered returns as impressive as  Vaxart (NASDAQ: VXRT) so far in 2020. The vaccine maker's shares skyrocketed more than 2,400% year to date by early July. And the stock is still up around 1,900%. Vaxart's successful performance stems primarily from investors' interest...

New York, New York--(Newsfile Corp. - August 25, 2020) -  Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Vaxart, Inc. ("Vaxart" or the "Company") (NASDAQ: VXRT) of the October 23, 2020 deadline to seek the role of lead plaintiff in a federal securit...

Cancer Genetics (NASDAQ: CGIX ) -16% . More news on: Cancer Genetics, Inc., Smith & Wesson Brands, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...